Improved GORE® DrySeal Sheath with Hydrophilic Coating Launches in Europe
New Product Engineered to Increase Sheath Lubricity, Minimize Coating Particulation for Easier Insertion and Removal in Treating Patients with AAA and TAA
Gore Launches Lower Profile GORE® EXCLUDER® AAA Endoprosthesis Contralateral Leg
Components in US and Europe
GORE® EXCLUDER® AAA Endoprosthesis Gore Completes Primary Enrollment for the Gore EXCLUDER® Iliac Branch Clinical Study
62 patients enrolled in US investigational device exemption clinical study to assess first complete, low-profile system for managing common iliac artery aneurysms or aorto-iliac aneurysms
Nominees Announced for 2016 Pioneers in Performance Awards for North America; Online Voting Opens at www.PioneersInPerformance.com
Awards program honors medical specialists advancing therapy and improving patient and clinical performance through active collaboration
Gore Launches Early Cannulation Capable GORE® ACUSEAL Vascular Graft
Results of early cannulation clinical trial presented at the 2013 VEITHsymposium
Study Confirms GORE® BIO-A® Tissue Reinforcement a Proven Alternative to Biologics in Hernia Repair
Two-year study demonstrates improved patient satisfaction with Gore material
Gore Marks 20th Year on 100 Best Companies to Work For® List
Gore has appeared in every edition of the rankings, published annually in Fortune magazine. The company is among just 12 “Great Place to Work Legends” to hold this distinction.
Gore Announces First-in-Human Use of GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System for TEVAR
New delivery system provides controlled and predictable placement of Gore’s highly conformable and time-tested stent graft
Gore Completes Patient Enrollment in U.S. Pivotal Clinical Study of GORE® CARDIOFORM ASD Occluder
New addition to GORE® CARDIOFORM Occluder family is designed to treat larger atrial septal defects by adapting to the patient’s anatomy for a permanent and safe closure